Related Experiment Video
Updated: Feb 24, 2026

09:45
Microfluidics-based High-throughput Circulating Tumor Cell Sorting and Single-cell Sequencing Technology
Published on: November 14, 2025
727
Circulating Tumor Cells: Moving Biological Insights into Detection
Lichan Chen1, Ann M Bode1, Zigang Dong1
1The Hormel Institute, University of Minnesota, 801 16th Ave NE, Austin, Minnesota 55912.
Theranostics
|August 19, 2017
Summary
Circulating tumor cells (CTCs) show promise as liquid biopsies for cancer detection and monitoring. Improving CTC enrichment and characterization methods is crucial for reliable clinical applications.
Area of Science:
- Oncology
- Biotechnology
- Molecular Diagnostics
Background:
- Circulating tumor cells (CTCs) are valuable biomarkers for non-invasive cancer diagnostics.
- Challenges in CTC analysis include low abundance and cellular heterogeneity.
- Current CTC detection methods require optimization for clinical utility.
Purpose of the Study:
- To review recent advancements in circulating tumor cell (CTC) biology.
- To summarize current CTC enrichment and characterization technologies.
- To critically evaluate methods for selecting appropriate CTC analysis techniques for clinical applications.
Main Methods:
- Literature review of CTC biology and detection technologies.
- Analysis of mechanisms of CTC generation and existence in circulation.
- Critical examination of CTC enrichment and characterization methodologies.
Main Results:
- CTCs offer potential for early cancer detection, prognosis, and treatment monitoring.
- Heterogeneity and low abundance of CTCs pose significant analytical challenges.
- Recent progress in CTC biology necessitates updated enrichment and characterization strategies.
Conclusions:
- Reliable CTC liquid biopsies depend on integrating biological insights with advanced analytical methods.
- Careful selection of CTC enrichment and characterization techniques is essential for clinical translation.
- Further research is needed to enhance the sensitivity and specificity of CTC analysis for improved patient outcomes.

